Magnetic resonance elastography reveals effects of anti-angiogenic glioblastoma treatment on tumor stiffness and captures progression in an orthotopic mouse model

Anti-angiogenic treatment of glioblastoma (GBM) complicates radiologic monitoring. We evaluated magnetic resonance elastography (MRE) as an imaging tool for monitoring the efficacy of anti-VEGF treatment of GBM.

Saved in:

Bibliographic Details
Main Authors:	Schregel, Katharina (Author) , Nowicki, Michal O. (Author) , Palotai, Miklos (Author) , Nazari, Navid (Author) , Zane, Rachel (Author) , Sinkus, Ralph (Author) , Lawler, Sean E. (Author) , Patz, Samuel (Author)
Format:	Article (Journal)
Language:	English
Published:	12 May 2020
In:	Cancer imaging Year: 2020, Volume: 20, Issue: 1
ISSN:	1470-7330
DOI:	10.1186/s40644-020-00314-1
Online Access:	Verlag, lizenzpflichtig, Volltext: https://dx.doi.org/10.1186/s40644-020-00314-1 Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/s40644-020-00314-1
Author Notes:	Katharina Schregel, Michal O. Nowicki, Miklos Palotai, Navid Nazari, Rachel Zane, Ralph Sinkus, Sean E. Lawler and Samuel Patz

Description
Summary:	Anti-angiogenic treatment of glioblastoma (GBM) complicates radiologic monitoring. We evaluated magnetic resonance elastography (MRE) as an imaging tool for monitoring the efficacy of anti-VEGF treatment of GBM.
Item Description:	Gesehen am 01.10.2020
Physical Description:	Online Resource
ISSN:	1470-7330
DOI:	10.1186/s40644-020-00314-1